Nuclide Therapeutics
Develops targeted radiopharmaceutical therapies for patients with treatment-resistant cancers
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-07
About Nuclide Therapeutics
Nuclide Therapeutics develops radiopharmaceutical therapies combining nuclear medicine and biotechnology, including diagnostic and therapeutic programs in preclinical evaluation and first-in-human studies.
The company aims to provide treatment options for patients with therapy-resistant cancers and limited alternatives. It is based in the United Kingdom and has a multidisciplinary founding team with expertise in chemistry, molecular biology and radiopharmaceutical development.
Product: Targeted radiopharmaceutical therapies and diagnostic programs for treatment-resistant cancers.
Jobs at Nuclide Therapeutics
Leadership
- Tim Witney · Co Founder & CSOSource: company website
- Muhammet Tanç · Co Founder & CEOSource: company website
- Matthias Untisz · CFOSource: company website
- Richard Edwards · Co Founder & CTOSource: company website
- Sofia Santos · Co Founder & COOSource: company website
More biotech & pharma companies
Octapharma
Plasma-derived medicines for patients with rare diseases, coagulopathies and bleeding disordersNew on EvolcOgi Bio
Automated modular bioreactors and culturing systems for scientists studying microbial growth and culturesNew on EvolcOMass Therapeutics
Drug discovery company developing small-molecule medicines for immunological and orphan diseasesNew on EvolcOppilotech
Computational biology modelling and drug discovery for pharmaceutical and biotech companiesNew on EvolcOptibrium
Drug discovery software for pharmaceutical, biotech and academic teams designing and selecting small-molecule compoundsNew on EvolcOpvia
AI-assisted GxP platform combining LIMS, MES, ELN and QMS for life-science labs and biomanufacturersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- FramerHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
